Condition
Gynecologic Cancer
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 84 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
60 shownExercise Oncology Clinic Pilot Feasibility TrialNCT07765927 · 2026-08-03
RECRUITINGCARE Tool Study Aim 3NCT07296887 · 2026-04-08
RECRUITINGStudy of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)NCT07524114 · 2026-03-31
RECRUITINGRiluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot TrialNCT07447050 · 2025-12-23
RECRUITINGThe Florida ASCENT StudyNCT07042243 · 2025-12-05
RECRUITINGPilot Observational Study of an Integrative Cure Stay ProgramNCT07398079 · 2025-10-06
RECRUITINGGuided Meditation During Radiation Therapy for Breast and Gynecological MalignanciesNCT07166042 · 2025-09-25
RECRUITINGTranscranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer SurvivorsNCT07120100 · 2025-08-27
RECRUITINGBrodalumab in the Treatment of Immune-Related Adverse EventsNCT06673329 · 2025-03-11
RECRUITINGRepurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialNCT06580002 · 2024-12-02
RECRUITINGStress Management Intervention Among Breast and Gynecologic Cancer Patients in Viet NamNCT06398067 · 2024-11-05
RECRUITINGPredicting Cancer Risk With Digital and Molecular MarkersNCT06962670 · 2024-09-14
RECRUITINGA Study of GC203 TIL in Advanced Malignant Solid TumorsNCT06375187 · 2024-05-29
RECRUITINGWeb-Based Application for Monitoring Radiation Therapy Complications in Cancer PatientsNCT07416630 · 2023-09-02
RECRUITINGRobotic-assisted Versus Conventional Laparoscopic Surgery in Obese Patients With Early Endometrial CancerNCT05974995 · 2023-09-01
RECRUITINGProspective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated TumorsNCT05313191 · 2022-01-24
RECRUITINGAvera Cancer Sequencing and Analytics Protocol (ASAP)NCT05142033 · 2021-11-01
RECRUITINGInterest of Circulating Tumor DNA in Digestive and Gynecologic/Breast CancerNCT04530890 · 2021-03-08
RECRUITINGInvestigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible SensitivityNCT04273061 · 2020-06-17
RECRUITINGThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyNCT04075305 · 2019-02-01
RECRUITINGDevelopment of Clinical and Biological DatabaseNCT03449264 · 2017-07-27
RECRUITINGFood-related Quality of Life in Patients With CancerNCT07437326 · 2026-03-01
NOT_YET_RECRUITINGClinical Investigation of the Effects of Semiconductor Embedded Therapeutic Garments on Cancer-related Cognitive Impairment in Breast and Gynecological Cancer PatientsNCT07173101 · 2025-11-07
TERMINATEDSomesthesia in Cancer Patients: Variability and Influence on Eating ExperienceNCT06803381 · 2025-03-13
NOT_YET_RECRUITINGLung Ultrasound in Critically Ill Obstetrics and Gynecological PatientsNCT06728709 · 2024-12-15
COMPLETEDDiet, Hepcidin, and Chemotherapy RDINCT06483997 · 2024-08-16
ACTIVE_NOT_RECRUITINGEvaluation of Hydroxychloroquine to Prevent CIPNNCT05689359 · 2024-06-01
WITHDRAWNPsychosexual Educational Partners Program (PEPP)NCT06253182 · 2024-04-02
ACTIVE_NOT_RECRUITINGMind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive InterventionNCT06168825 · 2024-01-17
COMPLETEDThe SOAR Study: a Study of Geriatric Assessment and Exercise for Older Adults and Their Support PersonNCT05509751 · 2023-10-01
ACTIVE_NOT_RECRUITINGA Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid TumorsNCT05961111 · 2023-06-24
UNKNOWNAdoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid TumorsNCT05902520 · 2023-06-19
ACTIVE_NOT_RECRUITINGFeasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) InterventionNCT05677048 · 2023-04-14
ACTIVE_NOT_RECRUITINGEvaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ TumorsNCT05704985 · 2023-04-03
ACTIVE_NOT_RECRUITINGA Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid TumorsNCT05860374 · 2023-03-02
UNKNOWNLong-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRsNCT05292859 · 2023-03-01
COMPLETEDImplementation of a Multimodal Prehabilitation Program in Robotic Oncological SurgeryNCT05671094 · 2023-01-13
COMPLETEDClinical Investigation of the da Vinci Surgical SystemNCT05682742 · 2022-12-12
ACTIVE_NOT_RECRUITINGPathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC)NCT05629065 · 2022-11-28
ACTIVE_NOT_RECRUITINGIntravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal CarcinomatosisNCT05185947 · 2022-10-13
COMPLETEDA Pilot Study to Evaluate the Use of the AMMA Portable Scalp Cooling System From Cooler HeadsNCT05365243 · 2022-08-15
WITHDRAWNThe BurnAlong Pilot Study for Adolescent and Young Adult Cancer SurvivorsNCT05131815 · 2022-07-25
COMPLETEDPhase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid TumorsNCT05194735 · 2022-04-04
TERMINATEDDeveloping a Psychosexual Educational Partners Program: PEPP A Feasibility StudyNCT05070299 · 2022-03-15
COMPLETEDCAncer, NUtrition and Taste 2NCT05027490 · 2022-01-27
COMPLETEDComparing Pre-Anesthesia Evaluation Via Telemedicine Versus in Person for Surgical Patients at Moffitt Cancer CenterNCT05065944 · 2021-11-16
COMPLETEDLow-dose Neuroleptanalgesia for Postoperative Delirium in Elderly PatientsNCT05068180 · 2021-10-05
UNKNOWNEvaluating Smoking Cessation Protocols in Cancer Patients: NRT, MI, CBT or HypnotherapyNCT04899492 · 2021-09-29
TERMINATEDOpening the Conversation StudyNCT04806724 · 2021-09-01
COMPLETEDAssessments of Genetic Counseling Augmented With an Educational Video or Pamphlet Versus Traditional CounselingNCT05132868 · 2021-05-25
COMPLETEDImproving Cancer Outcomes Through Personalized Care Planning and Symptom Management.NCT04772118 · 2021-02-16
COMPLETEDEffectiveness of Wound Drains for the Prevention Of Surgical sITe infectIONNCT05179122 · 2021-01-01
COMPLETEDEvaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer PatientsNCT04604158 · 2020-12-02
COMPLETEDA Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid TumorsNCT04682431 · 2020-11-10
TERMINATEDA Study of PY314 in Subjects With Advanced Solid TumorsNCT04691375 · 2020-10-29
TERMINATEDpoStoperative Anesthesia Care: Facial Mask vs Hfnc and Thoracic Ultrasound for Reduction of Atelectasis IncidenceNCT04566419 · 2020-10-01
COMPLETEDDietary Fiber During Radiotherapy - a Placebo-controlled Randomized TrialNCT04534075 · 2020-09-02
COMPLETEDPatient-Centered Intervention to Reduce Cancer Patients' Financial ToxicityNCT04314284 · 2020-05-26
COMPLETEDImpact of the COVID-19 Pandemic in Gynecological OncologyNCT04351139 · 2020-05-06
COMPLETEDRadiomic Analysis for Predicting Treatment Response and Clinical Outcomes in MalignanciesNCT05170087 · 2020-03-02
UNKNOWNCommon interventions
Neoantigen specific TCR-T cell drug productBIOLOGICAL2PlaceboDRUG2placeboOTHER2Radiation therapyRADIATION2Recombinant oncolytic herpes simplex virus type 1 (R130)DRUG2RiluzoleDRUG2'Doing What Matters in Times of Stress' (DWM) GuideOTHER110-15 minute, Audio-Recorded Guided Mediation PracticesBEHAVIORAL116 week waiting period + optional AcupunctureOTHER124 H feed back questionnaireBEHAVIORAL1AcupunctureDEVICE1AcupunctureOTHER1Aldesleukin (IL-2)BIOLOGICAL1AMMA Portalbe Scalp Cooling SystemDEVICE1Anthropometric measuresOTHER1APN InterventionOTHER1AtezolizumabDRUG1BayPass mobile applicationOTHER1biological collectionBIOLOGICAL1Biomaterial collectionOTHER1Blood samplesDIAGNOSTIC_TEST1BrodalumabDRUG1CANUT supportOTHER1Capsules containing either dietary fiber or placeboBIOLOGICAL1Cardiac coherenceOTHER1
Leading sponsors
Hospices Civils de Lyon
4
University of Utah
4
Memorial Sloan Kettering Cancer Center
3
Alaunos Therapeutics
2
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
2
Ikena Oncology
2
Institut du Cancer de Montpellier - Val d'Aurelle
2
Oregon State University
2
Sahlgrenska University Hospital
2
Shanghai Yunying Medical Technology
2
Stanford University
2
University of California, Irvine
2
Washington University School of Medicine
2
Weill Medical College of Cornell University
2
AgonOx, Inc.
1
Trial status mix
COMPLETED37
RECRUITING21
ACTIVE_NOT_RECRUITING9
TERMINATED6
UNKNOWN6
WITHDRAWN3
NOT_YET_RECRUITING2
Phase mix
NA45
PHASE18
PHASE28
PHASE33
EARLY_PHASE12
PHASE41
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.